eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2022
vol. 39
 
Share:
Share:
abstract:
Review paper

Demodicosis among immunocompromised patients: a review

Adriana Marquardt-Feszler
1
,
Karolina Cekała
1
,
Alicja Dębska-Ślizień
2
,
Beata Imko-Walczuk
3

  1. Medical University of Gdansk, Gdansk, Poland
  2. Department of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
  3. Dermatology and Venereology Outpatient Clinic, Copernicus, Independent Public Healthcare Centre, Gdansk, Poland
Adv Dermatol Allergol 2022; XXXIX (5): 829-837
Online publish date: 2022/11/09
View full text Get citation
 
Introduction
Demodex mites (DM) are the most common ectoparasites of humans. Demodex folliculorum and Demodex brevis are the two species we are hosts for. Through the years there have been more data proving DM to be a pathogenic parasite. To this date it has not clear which groups of patients are clearly prone to develop demodicosis.

Aim
To present a literature review in order to analyse and establish whether immunosuppressed patients are prone to develop demodicosis. Material and methods: Data were collected mostly from the PubMed database and through citation searching of the articles.

Results
A total amount of 23 case reports and 13 original works were included. Out of them, 4 original works deny the correlation between demodicosis and immunosuppression whereas 9 original works suggest that correlation.

Conclusions
Demodicosis seems to be correlated with immunosuppression, but it requires more study in the future.

keywords:

demodicosis, demodex folliculorum, immunosuppression, organ transplantation

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.